Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-21

Clinical Trial Update: An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A trial update evaluating the safety and effectiveness of bexagliflozin for essential hypertension across Phase 2 and Phase 3 stages; study completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bexagliflozin (null)

Snippet

Sponsor: Theracos | Conditions: Essential Hypertension | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-21